Methylmalonic Acidemia
·MeSH: Methylmalonic acidemia
Prevalence
5.0 / 100K
3 drugs in development·2 companies·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| mRNA-3705 | Moderna, Inc. (MRNA) |
Phase 2(1)
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| lb-001 | LogicBio Therapeutics, Inc. (LOGC) |
Compare drugs
Frequently asked questions
How many drugs are in development for Methylmalonic Acidemia?
BioSniper tracks 3 drugs in development for Methylmalonic Acidemia across 2 companies.
How many clinical trials target Methylmalonic Acidemia?
There are 3 clinical trials targeting Methylmalonic Acidemia tracked by BioSniper.
What is the prevalence of Methylmalonic Acidemia?
The estimated prevalence of Methylmalonic Acidemia is approximately 5.0 per 100,000 population.
Deep-dive into Methylmalonic Acidemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis